OPRX OptimizeRx Corporation
$9.19▲ +1.32%
Healthcare
Other
Volume 18.3K
Avg Volume (10D) 131.2K
Key Metrics & Fundamentals
Market Cap
$173.10M
P/E Ratio
38.3
Div Yield
0.00%
52W Range
4.54 - 21.56
% vs 50 MA
11.78%
% vs 200 MA
22.96%
RSI-14
60.7
MACD Histogram
+0.0400
Beta (1Y vs SPY)
1.99
Free Cash Flow
$8.58M
Gross Rev
$20.50M
Gross Profit
$15.69M
EBITDA
$1.10M
COGS
$4.82M
Operating Exp
$15.78M
Operating Income
-$88,000
EBIT
-$88,000
Pretax Income
-$1.10M
Net Income
-$703,000
EPS (Diluted)
-0.04
Price & Volume History
Loading chart…
Recent News
OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel
GlobeNewswire · Oct 27, 2026 7:30 AM ET
Trade Desk Integration and Programmatic Capabilities Drive OptimizeRx’s (OPRX) Q4 Catalyst
Insider Monkey · Oct 22, 2026 9:05 AM ET
What Trade Desk (TTD)'s Healthcare Inventory Integration With OptimizeRx Means For Shareholders
Simply Wall St. · Oct 2, 2026 9:10 AM ET
B. Riley Raises Price Target on OptimizeRx to $11 From $10, Keeps Buy Rating
MT Newswires · Sep 29, 2026 7:53 AM ET
Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?
Zacks · Sep 23, 2026 9:14 AM ET
OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad Network
Stocktwits · Sep 22, 2026 1:18 PM ET
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
GlobeNewswire · Sep 22, 2026 8:00 AM ET
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
GlobeNewswire · Sep 14, 2026 8:00 AM ET
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
GlobeNewswire · Sep 8, 2026 7:30 AM ET
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
GlobeNewswire · Sep 2, 2026 7:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See OPRX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.